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ABSTRACT
The exosome is a complex of 30–50 exoribonucleases
and RNA-binding proteins, which is involved in
processing or degradation of different classes
of RNA. Previously, the characterization of purified
exosome complexes from yeast and human cells
suggested that C1D and KIAA0052/hMtr4p are
associated with the exosome and thus might regu-
late its functional activities. Subcellular localization
experiments demonstrated that C1D and KIAA0052/
hMtr4p co-localize with exosome subunit PM/
Scl-100 in the nucleoli of HEp-2 cells. Additionally,
the nucleolar accumulation of C1D appeared to be
dependent on PM/Scl-100. Protein–protein interac-
tion studies showed that C1D binds to PM/Scl-100,
whereas KIAA0052/hMtr4p was found to interact
with MPP6, a previously identified exosome-
associated protein. Moreover, we demonstrate
that C1D, MPP6 and PM/Scl-100 form a stable
trimeric complex in vitro. Knock-down of C1D,
MPP6 and KIAA0052/hMtr4p by RNAi resulted
in the accumulation of 30-extended 5.8S rRNA
precursors, showing that these proteins are
required for rRNA processing. Interestingly, C1D
appeared to contain RNA-binding activity with a
potential preference for structured RNAs. Taken
together, our results are consistent with a role for
the exosome-associated proteins C1D, MPP6 and
KIAA052/hMtr4p in the recruitment of the exosome
to pre-rRNA to mediate the 30 end processing of
the 5.8S rRNA.
INTRODUCTION
The human exosome is a complex with 30–50 exoribo-
nuclease activity, consisting of nine core components and
the stably associated component PM/Scl-100, which is
more abundant in but not restricted to the nucleus (1,2).
Six of the core components (hRrp41p, hRrp42p,
hRrp46p, hMtr3p, OIP2 and PM/Scl-75) contain an
RNase PH domain, which assemble into a hexameric
ring structure, whereas the three remaining components
(hRrp4p, hRrp40p and hCsl4p) containing an S1 (and
KH) RNA-binding domain are positioned on top of this
ring (3–8).
A variety of nuclear functions have been described
for the yeast exosome, including 30 end processing
of sn(o)RNAs (9,10) and the degradation of aberrant
pre-mRNAs (11–13) and pre-tRNAs (14,15). In the
nucleolus of eukaryotes, the 18S, 5.8S and 25S/28S
rRNAs are transcribed as a single precursor by RNA
polymerase I. After transcription, maturation of rRNAs is
achieved by a complex processing pathway in which many
nucleotide-modiﬁcation events occur and in which the
two internally transcribed spacers (ITS1 and ITS2) and
two externally transcribed spacers (50-ETS and 30-ETS)
are removed (16,17). In yeast, depletion of exosome
components as well as several associated proteins such
as Rrp47p and Mtr4p resulted in the accumulation
of 30-extended 5.8S rRNAs, elevated levels of 50 ETS
fragments, and polyadenylated (pre-)rRNAs. Exosome
depletion also indirectly aﬀected early pre-rRNA cleavage
events at A(0), A(1), A(2) and A(3) leading to a reduction
of the mature 18S and 25S rRNAs (9,18–25).
Besides the core exosome components, several
cytoplasmic and nuclear exosome-associated proteins
have been identiﬁed which are most likely required
for the recruitment of the exosome to speciﬁc substrate
RNAs, its association with other processing complexes,
or the modulation of its in vivo activity. Nuclear exosome-
associated proteins include human MPP6, a protein
required for the maturation of the 5.8S rRNA, and
yeast Rrp47p (also known as C1D and Lrp1p), which
functions in sn(o)RNA and pre-rRNA processing
(2,26,27). The putative human homolog of yeast
Rrp47p/C1D/Lrp1p is the C1D protein, which has
previously been identiﬁed as a DNA-binding protein
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involved in DNA double-strand break repair by activating
a DNA-dependent protein kinase (28,29). The putative
RNA helicase Mtr4p is another auxiliary protein required
for most of the functions of the nuclear exosome in yeast
(9,30). The Mtr4p protein is also part of the recently
identiﬁed TRAMP complex, which is required for the
activation of the nuclear exosome in vivo by polyade-
nylation of target RNAs (15,21). The KIAA0052 protein
is the putative human homolog of Mtr4p and was found
to co-purify with the human exosome (31).
In this study, we investigated the exosome association
and function of C1D and KIAA0052, which hereafter
will be referred to as hMtr4p, in human cells. Our data
indicate that PM/Scl-100 mediates the association of
hMtr4p, C1D and MPP6 with the exosome and that
hMtr4p and the complex formed by PM/Scl-100, C1D and
MPP6 are required for the maturation of 5.8S rRNA.
MATERIALS AND METHODS
cDNA cloning
The cDNA of human C1D was obtained by a PCR-based
approach using a teratocarcinoma cDNA library and
oligonucleotides C1D-forward, 50-CGTCGACTTCTCG
AGATGGCAGGTGAAGAAATTAATG-30 and C1D-
reverse, 50-AGCGGCCGCTTACCCGGGACTTTTACT
TTTTCCTTTATTGG-30. The human hMtr4p cDNA
sequence was isolated by PCR from clone IRATp970F
0129D6 provided by the IMAGE consortium using
oligonucleotides hMtr4p-forward, 50-GCGACGATAT
CCTCGAGCATGGCGGACGCATTCGGAGA-30 and
hMtr4p-reverse 50-GCGTCGGTACCCTACAAGTAGA
GGCTGGCA-30. The resulting PCR products were
cloned into the pCR4-TOPO vector according to the
manufacturer’s procedure (Invitrogen).
Immunoprecipitation
Polyclonal rabbit anti-EGFP antibodies were coupled
to protein A-agarose beads (Kem-En-Tec) in IPP500
[(500mM NaCl, 10mM Tris-HCl, pH 8.0 and 0.05%
Nonidet P-40 (NP-40)] at room temperature for 1 h. Beads
were washed once with IPP500 and twice with IPP150
(same as IPP500, but containing 150mM NaCl). For each
immunoprecipitation, cell extract was incubated with the
antibody-coupled beads for 2 h at 48C. After washing the
beads four times with IPP150, the precipitated proteins
were separated by 10% SDS-PAGE and analyzed by
immunoblotting.
Western blot analysis
For western blot analysis, proteins were separated by
SDS-PAGE and transferred to nitrocellulose membranes.
After blocking, the blots were incubated with autoimmune
patient antisera or monoclonal anti-hRrp4p antibodies
(culture supernatant) (ModiQuest, Nijmegen, The
Netherlands), diluted 1000- and 25-fold, respectively,
in blocking buﬀer (5% skimmed milk, 0.05% NP-40 in
PBS). As secondary antibodies, horseradish peroxidase-
conjugated rabbit anti-human IgG or goat anti-mouse
IgG (Dako Immunoglobulins) were used, 2500-fold
diluted in blocking buﬀer. Bound antibodies were visual-
ized by chemiluminescence detection.
Expression and purification of recombinant proteins
For prokaryotic expression, the C1D and MPP6 cDNAs
were cloned into the pGEX4 vector, resulting in sequences
encoding glutathione S-transferase (GST)-tagged recom-
binant proteins. The GST fusion proteins were expressed
and puriﬁed essentially as described previously (32).
After induction of protein expression with IPTG, the
bacteria were grown at room temperature to enhance the
production of soluble protein. The proteins were puriﬁed
using a reduced glutathione aﬃnity resin in the presence
of 0.2% empigen and stored at 708C after the addition
of glycerol (ﬁnal concentration 10%).
In vitro transcription and translation
The open reading frames of PM/Scl-100, MPP6 and C1D
were cloned into the pCI-neo vector (Promega), in frame
with the vesicular stomatitis virus G epitope (VSV-G tag).
The resulting pCI-neo50VSV constructs of PM/Scl-100,
MPP6 and C1D as well as a pCR4-TOPO-hMtr4p
construct were transcribed and translated in the presence
of 35S-methionine using the TnT-coupled transcription/
translation kit (Promega).
Transient transfection and fluorescence microscopy
The cDNAs were cloned into suitable pEGFP vectors
(Clontech) allowing expression of the protein fused to the
C-terminus of the EGFP protein. HEp-2 cells were grown
to 70% conﬂuency in DMEM containing 10% fetal
calf serum (FCS) (DMEMþ). For immunoprecipitation,
10 106 cells were transfected with 30 mg of plasmid
DNA in 1600 ml of DMEMþ by electroporation at 260V
and 950 mF using a Gene-Pulsar II (Bio-Rad). After
transfection, cells were seeded in 75-cm2 culture ﬂasks and
cultured overnight. The trypsinized cells were washed
with PBS, resuspended in 750 ml of lysis buﬀer (25mM
Tris-HCl, pH 7.5, 150mM KCl, 2mM EDTA,
1mM dithiotreitol (DTT), 0.5mM PMSF and 0.05%
NP-40) and homogenized by sonication using a Branson
micro-tip. For ﬂuorescence microscopy 3 106 cells
were transfected with 10 mg of plasmid DNA in 800 ml
DMEMþ by electroporation as described above. The
cells were seeded on coverslips and cultured overnight.
Subsequently, the cells were washed twice with PBS
and ﬁxed with 4% paraformaldehyde in PBS for 20min.
After ﬁxation, cells were washed three times with PBS
and mounted with 50% glycerol in PBS. The EGFP-
fusion proteins were visualized by ﬂuorescence microscopy
using a Leica DM IRBE confocal microscope. For
co-localization experiments, HEp-2 cells were transfected
with pEGFP-C1D or pEGFP-hMtr4p and grown on
coverslips for 24 h. Cells were ﬁxed with methanol for
5min at 208C, brieﬂy rinsed in acetone, air dried
and incubated for 1 h at room temperature with
anti-PM/Scl-100 rabbit serum (diluted 1:100 in PBS),
followed by washing and incubation with secondary
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Texas-Red-conjugated donkey anti-rabbit IgG. The cells
were analyzed by confocal ﬂuorescence microscopy.
siRNA transfection experiments
The 21-nt siRNA duplexes used in this study are based
on the coding region of the gene of interest, containing
dTdT overhangs and were obtained from Eurogentec
(Belgium): siC1D, 50-GUUGGAUCCACUUGAACAA
TT-30; siPM/Scl-75, 50-GCCAAGAUGCUCCCAUAAU
TT–30; sihMtr4p, 50-GCCUAUGCACUUCAAAUGATT-30.
The siRNAs against human MPP6 and PM/Scl-100 were
described previously (1,2). The siRNA negative control
(OR-0030-NEG05) was obtained from Eurogentec,
Belgium. For each transfection, 3 105 HEp-2 cells
were transfected with 100 pmol of each siRNA using
Oligofectamine transfection reagent (Invitrogen), as
described by the manufacturer with the exception that
during transfection 10% FCS was present in the medium.
Total RNA was extracted 48 h after transfection using the
TRIzol reagent (Invitrogen). For each sample, 5 mg of
total RNA was separated on a denaturing 7% polyacryl-
amide gel, and after transfer to Hybond Nþ membranes
(Amersham Biosciences) the blots were hybridized
with 32P-labeled antisense RNA probes in hybridization
solution (6 SSC, 10 Denhardt’s, 100 mg/ml sheared
herring sperm DNA and 0.1% SDS). After overnight
incubation at 658C, the blots were washed three times with
2 SSC/0.1% SDS and analyzed by autoradiography.
To study the subcellular localization of C1D in
siRNA-treated cells, HEp-2 cells were transfected with
C1D-EGFP as described above. After 16 h, cells were
treated with 100 pmol of siRNA and cultured overnight.
Subsequently, the cells were washed twice with PBS,
ﬁxed with 4% paraformaldehyde in PBS for 20min
and mounted in PBS/glycerol. Expressed proteins were
visualized by ﬂuorescence microscopy using a Leica
DM4000B microscope.
GST pull-down
GST-fusion protein (1 mg) was immobilized on
glutathione-Sepharose beads (Amersham Pharmacia
Biotech), washed with pull-down buﬀer PB-100 (PB-100:
20mM HEPES-KOH, pH 7.6, 100mM KCl, 0.5mM
EDTA, 0.05% NP-40, 1mM DTT, 5mM MgCl2, 0.02%
BSA, 0.5mM PMSF) and incubated with in vitro
translated, 35S-labeled protein at 48C for 2 h under contin-
uous agitation. After incubation, the beads were washed
three times with PB-150 (composition like PB-100, but
containing 150mM KCl), and the bound proteins were
analyzed by SDS-PAGE and autoradiography. In case
of protein–RNA interactions, immobilized GST-C1D
was resuspended in 200 ml of PB-200 (composition like
PB-100, but containing 200mM KCl and lacking MgCl2).
After addition of the 32P-labeled RNAs and 20 U of
RNasin (Promega), the mixture was incubated for 1 h at
48C under continuous agitation. The beads were washed
four times with PB-200, and the co-precipitating RNAs
were extracted and analyzed by denaturing PAGE and
autoradiography.
RESULTS
C1D and hMtr4p co-localize with PM/Scl-100
in the nucleoli of HEp-2 cells
To determine the subcellular localization of C1D and
hMtr4p, HEp-2 cells were transiently transfected with
constructs encoding EGFP-tagged C1D, hMtr4p, MPP6
or the core exosome component PM/Scl-75. After 24 h,
the EGFP fusion proteins were visualized by confocal
ﬂuorescence microscopy (see Figure 1). In agreement
with previous observations, EGFP-PM/Scl-75 and EGFP-
MPP6 accumulated in the nucleoli, whereas also a weak
but signiﬁcant staining of the nucleoplasm was observed
for both proteins (2,33) A very similar staining pattern
was observed for both EGFP-C1D and EGFP-hMtr4p.
Thus, the subcellular distribution of C1D and hMtr4p is
consistent with their putative exosome association.
To investigate this more thoroughly, HEp-2 cells were
transfected with either EGFP-C1D or EGFP-hMtr4p
and also stained with an antibody to the exosome subunit
Figure 1. C1D and hMtr4p co-localize with PM/Scl-100 in the nucleoli
of HEp-2 cells. (A) HEp-2 cells were transiently transfected with cDNA
constructs encoding EGFP alone, EGFP-PM/Scl-75, EGFP-MPP6,
EGFP-C1D or EGFP-hMtr4p. Twenty-four hours after transfection,
the cells were ﬁxed and EGFP or EGFP-fusion proteins were visualized
by confocal ﬂuorescence microscopy. (B) HEp-2 cells were transfected
with cDNA constructs encoding C1D and hMtr4p fused to the C-
terminus of EGFP; 24 h after transfection, cells were ﬁxed and
incubated with rabbit anti-PM/Scl-100 antibodies, which were visua-
lized by Texas-Red-conjugated secondary antibodies (left panels). The
localization of EGFP-tagged C1D and hMtr4p is shown in the middle
panels, and the corresponding merged images are shown on the right.
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PM/Scl-100. As shown in Figure 1B, a nearly complete
co-localization of EGFP-C1D and EGFP-hMtr4p with
PM/Scl-100 in the nucleoli of these cells was observed.
In the nucleoplasm, there appears to be less extensive
co-localization, which might be due to the low levels of
protein present in this subcellular compartment and/or to
overexpression of the EGFP-fusion proteins.
Interaction of C1D and hMtr4p with the exosome
To investigate whether C1D is indeed associated with the
human exosome, immunoprecipitations with anti-EGFP
antibodies were performed with lysates from HEp-2
cells expressing EGFP-tagged C1D, PM/Scl-75 or EGFP
alone as a negative control. Co-precipitated material
was analyzed by western blotting using a human patient
serum (known to be reactive with PM/Scl-100) and a
monoclonal antibody to the human exosome component
hRrp4p. As expected, both PM/Scl-100 and hRrp4
were co-precipitated with the EGFP-PM/Scl-75 protein
(Figure 2A, lane 3). PM/Scl-100 and hRrp4p also
appeared to be co-precipitated with EGFP-C1D
(lane 4), although the eﬃciency of hRrp4p co-precipita-
tion was much lower than that observed with EGFP-PM/
Scl-75. With the EGFP protein alone no co-precipitation
of hRrp4p and PM/Scl-100 was detected (lane 2).
This result suggests that C1D is preferentially associated
with exosome complexes containing PM/Scl-100. To
substantiate the direct interaction of C1D and MPP6,
another protein reported to interact with PM/Scl-100 (5),
with PM/Scl-100, immunoprecipitations were performed
using recombinant His-tagged PM/Scl-100 and in vitro
translated glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), C1D and MPP6. As shown in Figure 2B,
precipitation of His-PM/Scl-100 by anti-PM/Scl-100 anti-
bodies resulted in the eﬃcient co-precipitation of C1D
(lane 6) and, albeit to a lesser extent, MPP6 (lane 9), but
not GAPDH (lane 3). In lanes 2, 5 and 8, anti-PM/Scl-100
antibodies were incubated with the in vitro translated
proteins in the absence of His-PM/Scl-100 demonstrating
that the antibodies are not reactive with either of these
proteins. In the reciprocal experiment, precipitation of
GST-fusion proteins using glutathione-Sepharose beads
resulted in the co-precipitation of in vitro translated PM/
Figure 2. Association of C1D, MPP6 and hMtr4p with components of the exosome. (A) Co-immunoprecipitations were performed using anti-EGFP
antibodies and extracts of HEp-2 cells transiently transfected with expression constructs for either EGFP alone (lane 2), EGFP-PM/Scl-75 (lane 3) or
EGFP-C1D (lane 4). In the ﬁrst lane, total extract from non-transfected HEp-2 cells was separated. The precipitated proteins were analyzed by
western blotting, using anti-PM/Scl-positive patient serum R212 (upper part of the blot) or a monoclonal antibody to hRrp4p (lower part of
the blot). Arrows indicate the positions of PM/Scl-100 and hRrp4p. The positions of molecular weight markers are indicated on the left. (B)
Bacterially expressed, recombinant His-tagged PM/Scl-100 was immobilized using anti-PM/Scl-100 antibodies and incubated with either 35S-labeled,
in vitro translated GAPDH (lane 1), C1D (lane 4) or MPP6 (lane 7). Co-precipitated proteins were analyzed by SDS-PAGE and autoradiography.
The positions of these proteins are indicated with arrows, and the positions of molecular weight markers are indicated on the left. Lanes 3, 6 and 9
show proteins co-precipitated with His-PM/Scl-100. In lanes 2, 5 and 8, material from control incubations, in which no recombinant His-PM/Scl-100
was added, was analyzed. (C) Glutathione-Sepharose beads were used to precipitate GST (lane 2), GST-C1D (lane 3) or GST-MPP6 (lane 4), which
were incubated with 35S-labeled, in vitro translated PM/Scl-100. After precipitation, bound PM/Scl-100 was analyzed by SDS-PAGE and
autoradiography. In lane 1, 10% of the amount of labeled PM/Scl-100 used per incubation was loaded. On the left, the positions of molecular weight
markers are indicated. (D) Similar experiments as described in (C), but now with 35S-labeled, in vitro translated hMtr4p instead of PM/Scl-100.
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Scl-100 with both GST-C1D and, although less eﬃciently,
with GST-MPP6, but not with GST alone (Figure 2C).
To identify protein–protein interactions of hMtr4p with
the exosome, GST pull-down assays were performed using
GST-fusion proteins of several exosome components and
auxiliary proteins and in vitro translated hMtr4p. The
only protein found to speciﬁcally interact with hMtr4p
was GST-MPP6 as shown in Figure 2D, whereas none
of the other proteins analyzed (C1D, hRrp4p, hRrp40p,
hRrp41p, hRrp42p, hRr46p, hMtr3p, OIP2 and hCsl4p)
were able to precipitate hMtr4p (data not shown). Because
the in vitro translated protein samples contain RNA, the
possibility existed that the observed protein–protein
interactions between GST-MPP6 and hMtr4p as well as
GST-C1D and PM/Scl-100 might be RNA-mediated.
Similar GST pull-down experiments were performed
with in vitro translated protein samples that were treated
with RNase A and RNase T1. The results demonstrated
that these protein–protein interactions were not aﬀected
by RNase treatment, even though control experiments
showed that the RNAs were eﬃciently degraded (data
not shown).
PM/Scl-100, C1D andMPP6 form
a heterotrimeric complex
The ﬁnding that both MPP6 and C1D interact with
PM/Scl-100 prompted us to examine the possibility that
MPP6 and C1D bind simultaneously to PM/Scl-100. GST
pull-down experiments were performed using GST-C1D
and in vitro translated C1D, MPP6 and PM/Scl-100 pro-
teins. As can be seen in Figure 3, no detectable interaction
was found between GST-C1D and in vitro translated C1D
or MPP6 (lanes 5 and 6). In contrast, GST-C1D eﬃciently
interacted with PM/Scl-100 as observed before (lane 7).
When both radiolabeled PM/Scl-100 and MPP6 were
incubated with GST-C1D, not only PM/Scl-100 but
also MPP6 was recovered in the precipitate (lane 8),
demonstrating that C1D, MPP6 and PM/Scl-100 form
a heterotrimeric complex in vitro. With the control, GST
alone, no detectable interaction was observed with
radiolabeled C1D, MPP6 or PM/Scl-100 (lane 4).
PM/Scl-100 is required for the nucleolar
localization of C1D
Both MPP6 and PM/Scl-100 contain a putative nuclear
localization signal. C1D on the other hand does not have
such a sequence motif raising the question whether
PM/Scl-100 and/or MPP6 is/are required for the nuclear
localization of C1D. To investigate this possibility,
we transfected HEp-2 cells with a C1D-EGFP construct
and after overnight incubation the cells were treated
with siRNAs directed against PM/Scl-75, MPP6 and PM/
Scl-100, or a control siRNA. The reduction in protein
levels was monitored by western blotting, which conﬁrmed
the eﬃciency of the siRNAs used (Figure 4A). The results
shown in Figure 4B demonstrate that upon knock-down
of PM/Scl-100 the nucleolar accumulation of C1D is
abrogated, whereas its localization was not aﬀected
upon knock-down of PM/Scl-75 or MPP6. Also, when
the HEp-2 cells were transfected with the control siRNA,
no change in the localization of C1D was observed.
Although these results suggest that PM/Scl-100 is required
for nucleolar localization of C1D, it is also possible
that PM/Scl-100 knock-down reduced the stability of
C1D-EGFP which might result in a cleaved EGFP
fragment and the ﬂuorescence pattern as observed in
Figure 4B, panel PM/Scl-100 siRNA. To rule out the
latter possibility, cell extracts of the transfected HEp-2
cells were analyzed by western blotting using anti-EGFP
antibodies. The results shown in Figure 4C demonstrate
that knock-down of PM/Scl-100 did neither result in the
detection of EGFP-containing degradation products
nor in a signiﬁcant change of the amount of full-length
C1D-EGFP. In this regard, it is also important to note
that knock-down of PM/Scl-100 did not result in
co-depletion of other exosome components, such as
hRrp4, hRrp41, hRrp46 or PM/Scl-75. Taken together,
these data show that the nucleolar accumulation of
C1D is depending on its interaction with PM/Scl-100.
Knock-down of exosome components PM/Scl-75 or PM/
Scl-100 had no eﬀect on the subcellular localization
of hMtr4p and MPP6 in similar experiments (data
not shown).
C1D and hMtr4p are required for the maturation
of the 5.8S rRNA
The nucleolar accumulation of both C1D and hMtr4p,
as well as their association with the exosome, suggested
that both proteins might play a role in the processing
of pre-rRNAs. In yeast, it has been demonstrated that the
maturation of the 30 end of the 5.8S rRNA requires
the exosome as well as several auxiliary proteins including
Rrp47p and Mtr4p (9,26,30). Recently, we demonstrated
that the exosome and MPP6 are involved in this process
in human cells (2).
Figure 3. C1D, MPP6 and PM/Scl-100 form a trimeric complex
in vitro. GST-tagged C1D was incubated with either 35S-labeled,
in vitro translated C1D (lane 5), MPP6 (lane 6), PM/Scl-100 (lane 7) or
MPP6 and PM/Scl-100 (lane 8). As a control, GST alone was incubated
with all three labeled proteins (lane 4). After incubation, GST(-C1D)-
containing complexes were precipitated with glutathione-Sepharose
beads and analyzed by SDS-PAGE and autoradiography. In lanes 1–3,
the in vitro translated C1D, MPP6 and PM/Scl-100 proteins were
analyzed.
2568 Nucleic Acids Research, 2007, Vol. 35, No. 8
To investigate the involvement of C1D and hMtr4p in
pre-rRNA processing, RNAi experiments were performed
by transfection of HEp-2 cells with siRNAs directed
against PM/Scl-100, MPP6, hMtr4p or C1D. Two days
later RNA was isolated and analyzed by northern blot
hybridization using a radiolabeled probe speciﬁc for the
5.8S rRNA (Figure 5A). The results demonstrate that
knock-down of all four proteins leads to the accumulation
of similar 5.8S rRNA precursors. The size of the faster
migrating processing intermediate seemed to diﬀer slightly
between the RNAs from the cells in which these proteins
were depleted. The same processing intermediates were
detected with a probe speciﬁc for ITS2, which indicates
that these 5.8S rRNA precursors are extended at their
30 end (Figure 5B). Probing for other ribosomal processing
intermediates such as 50 ETS fragments did not result
in detectable accumulation of processing intermediates
corresponding to this part of the primary transcript
(data not shown).
C1D is an RNA-binding protein
The results of the experiments described above demon-
strate that the exosome together with MPP6, C1D
and hMtr4p forms a multi-subunit complex involved
in the 30–50 processing of nucleolar and possibly also
nuclear RNA. This raises the question how these diﬀerent
components cooperate in this process. MPP6 has been
shown to contain RNA-binding activity with preference
for pyrimidine-rich sequences, which is predicted to be
involved for the recruitment of the exosome to RNA
substrates (2). The Mtr4p protein is a putative RNA
helicase which is most likely required for resolving
secondary structures that inhibit nucleolytic processing
by the exosome (30). The C1D protein has been reported
to be a member of the family of non-histone polypeptides
involved in higher order chromatin folding (28), of which
some have been found to be associated with highly
repetitive DNA sequences (34). We conducted GST pull-
down experiments to investigate whether C1D is also
able to bind to RNA. GST-C1D was immobilized using
glutathione-Sepharose beads, incubated with diﬀerent
32P-labeled homopolynucleotides and the bound RNAs
were quantiﬁed in a scintillation counter. The results in
Figure 6 show that GST-C1D binds eﬃciently to poly(G),
whereas no binding to poly(A), poly(C), poly(U) or
poly(I)–poly(C) was observed. Additional experiments
Figure 4. Nucleolar accumulation of C1D requires PM/Scl-100. HEp-2 cells were transfected with a construct encoding C1D fused to the N-terminus
of EGFP and 16 h after transfection cells were treated with a control siRNA (lanes 1, 3 and 5), or siRNAs targeting PM/Scl-75 (lane 2), MPP6
(lane 4) or PM/Scl-100 (lane 6). (A) After 24 h, cells were harvested, and total cell extracts were analyzed by western blotting using a polyclonal anti-
PM/Scl-75 serum (lanes 1 and 2), a polyclonal anti-MPP6 serum (lanes 3 and 4) and a polyclonal anti-PM/Scl-100 serum (lanes 5 and 6). A
mouse monoclonal antibody to gamma tubulin was used as a control. (B) Twenty-four hours after siRNA treatment, cells were ﬁxed and
the expressed C1D-EGFP fusion protein was visualized by ﬂuorescence microscopy. Panel control siRNA, cells treated with a control siRNA;
panel PM/Scl-75 siRNA, cells treated with the siRNA targeting PM/Scl-75; panel MPP6 siRNA, cells treated with the siRNA targeting MPP6;
panel PM/Scl-100 siRNA, cells treated with the siRNA targeting PM/Scl-100. (C) To investigate the integrity of the C1D-EGFP fusion protein upon
PM/Scl-100 siRNA-mediated knock-down, extracts were prepared from the transfected HEp-2 cells and analyzed by western blotting using a
polyclonal anti-EGFP antiserum. A mouse monoclonal antibody directed against gamma tubulin was used as a control.
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showed that C1D indeed binds to G-rich RNAs such as
the ITS1, but also to tRNAs, which lack G-rich sequences,
suggesting that the structure of the RNA may be
important for C1D binding as well (data not shown).
DISCUSSION
Although the molecular mechanisms by which the exo-
some is recruited to diﬀerent RNA substrates is poorly
understood, it is believed that in most cases auxiliary
proteins are involved. Also, the processing or degrada-
tion of RNAs by the exosome may require additional
proteins, such as helicases to resolve stable structures
in the substrates. Here, we report the characterization of
the association of the human C1D and hMtr4p proteins
with the exosome and their involvement in pre-rRNA
processing. Our data demonstrate that both C1D and
hMtr4p accumulate in the nucleus with the highest
concentrations found in the nucleoli. In addition, the
results of our experiments provide insight into the way
these proteins associate with the exosome. hMtr4p
interacts with MPP6, which in turn binds to PM/
Scl-100, C1D appeared to bind directly to PM/Scl-100.
The binding of MPP6 and C1D to PM/Scl-100 is not
mutually exclusive. The involvement of hMtr4p, MPP6
and C1D with exosome-mediated processing of pre-rRNA
may be explained by the putative RNA helicase activity
of hMtr4p and the RNA-binding capacity of MPP6
and C1D.
Identification of C1D and hMtr4p as auxiliary
proteins for the human exosome
Strong support for the association of hMtr4p with the
human exosome was already obtained several years ago
by the co-puriﬁcation of this protein with the TAP-tagged
exosome complex from human cells (31). The exosome
association of C1D was predicted based on the interaction
of its yeast counterpart Rrp47p with the yeast exosome
(26,35). The relatively low level of co-precipitation of
hRrp4p with EGFP-C1D in comparison with PM/Scl-100
(Figure 2A) suggests that C1D is preferentially associated
with exosome complexes containing PM/Scl-100. This
is further supported by the direct interaction between C1D
and PM/Scl-100 in both GST pull-down experiments.
Moreover, in a mammalian two-hybrid system C1D
interacted with PM/Scl-100, but failed to interact with
all other exosome subunits (data not shown). The binding
of MPP6 to both hMtr4p and PM/Scl-100 is consistent
with previously published yeast two-hybrid data (5).
In combination with the observation that C1D and
MPP6 can bind simultaneously to PM/Scl-100, these
data strongly suggest that the complex of C1D, MPP6 and
PM/Scl-100 interacts with the exosome by virtue of the
binding of PM/Scl-100 with the exosome. In this model,
hMtr4p associates via its interaction with MPP6, although
we have not yet succeeded in demonstrating the simul-
taneous binding of PM/Scl-100 and hMtr4p to MPP6.
In agreement with this mode of assembly, the depletion
of C1D or MPP6 did not interfere with the ability of PM/
Scl-100 to interact with the core exosome, as monitored
by Rrp4p co-immunoprecipitation (data not shown). The
PM/Scl-100 protein is a putative 30–50 exoribonuclease
with a conserved RNase D and HRDC (helicase and
RNase D C-terminal) domain (36). Although, no known
protein motifs can be identiﬁed in the primary structure
of C1D, the protein was proposed to bind to the
30-overhanging ends of DNA during repair (28,29).
Here, we demonstrate that the nucleic-acid-binding
capacity of C1D is not restricted to DNA, but that it
also eﬃciently binds to structured RNAs including
poly(G). Interestingly, we recently reported that MPP6
is also a RNA-binding protein, which preferentially
binds to pyrimidine homopolymers (2). Thus, various
Figure 5. Knock-down of hMtr4p and C1D leads to the accumulation
of 5.8S rRNA precursors. HEp-2 cells were transiently transfected with
siRNAs directed to PM/Scl-100 (lane 2), MPP6 (lane 3), hMtr4p
(lane 4), C1D (lane 5) or with a control siRNA (lane 1). Cells were
harvested 2 days after transfection and 2.5 mg of total RNA was
analyzed by northern blot hybridization using radiolabeled probes
speciﬁc for 5.8S rRNA (left) or ITS2 (upper right). As a control, a U6
snRNA probe was used (lower right). The positions of the 5.8S rRNA
precursors are indicated by arrows and the position of mature 5.8S
rRNA is indicated with an asterisk.
Figure 6. C1D binds RNA in vitro. GST and GST-C1D were incubated
with radiolabeled homopolynucleotides and bound RNAs were quanti-
ﬁed in a scintillation counter. The binding eﬃciency of GST and
GST-MPP6 to poly(A), poly(C), poly(G), poly(U) and poly(I)–poly(C)
is depicted as a percentage of input RNA (RBE: relative binding
eﬃciency). These results are the average values of two independent
experiments.
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RNA-binding speciﬁcities are associated with the exosome
via PM/Scl-100 and therefore it will be interesting to
investigate whether these contribute to the selectivity of
PM/Scl-100 and/or the exosome for substrate RNAs.
PM/Scl-100 is required for the nucleolar
accumulation of C1D
Nuclear entry of exosome-associated proteins may be
facilitated by protein–protein interactions occurring in the
cytoplasm and may proceed via a piggyback mechanism.
Knock-down of exosome components or one of the
auxiliary proteins did not aﬀect the subcellular localiza-
tion of hMtr4p and MPP6 (data not shown). Thus,
these proteins seem to be capable to enter the nucleus
independently of their association with components of the
exosome. Knock-down of PM/Scl-100, on the other hand,
led to reduced expression levels of C1D and abrogated
the nucleolar accumulation of C1D. The PM/Scl-100
protein contains a putative nuclear localization signal
(NLS; aa 752–758, AKKRERA). Since C1D binds very
eﬃciently to PM/Scl-100, it is likely that C1D is dependent
on PM/Scl-100 to enter the nuclei and to accumulate in
the nucleoli. The MPP6 protein binds less eﬃciently to
PM/Scl-100 in vitro and appears to enter the nucleus
independently of PM/Scl-100, which might be mediated
by the putative bipartite NLS (aa 116–132) in MPP6.
Taken together, these data suggest that the identiﬁed
exosome-associated proteins are transported to the nuclei
via distinct mechanisms.
5.8S rRNA processing requires multiple human exosome
auxiliary proteins
In yeast, the exosome was initially identiﬁed as a complex
required for the exonucleolytic 30 end maturation of the
5.8S rRNA (22). Later, it became evident that even for this
relatively simple processing step the core exosome requires
additional protein factors, such as Rrp6p, Rrp47p and
Mtr4p (9,19,26,30). Here, we have shown that besides the
core exosome and PM/Scl-100 at least three additional
proteins, C1D, MPP6 and hMtr4p, are involved in 5.8S
rRNA maturation in human cells. In yeast, the depletion
of core exosome components, Rrp6p, Rrp47p or Mtr4p
results in the accumulation of diﬀerent 5.8S rRNA-
processing intermediates (18,19,26,30). In the human
system, no major diﬀerences in the accumulation of 5.8S
rRNA precursors were observed after knock-down of
PM/Scl-100, C1D and hMtr4p. Previously, accumulation
of similar precursors was also observed after depletion of
hRrp41p and the exosome-associated protein MPP6 (2).
The observed diﬀerences between the yeast and human
systems may be explained by the depletion of the whole
exosome from the site of processing upon knock-down
of auxiliary proteins of the exosome in the human system.
Besides rRNA processing yeast Rrp47p and Mtr4p were
shown to be involved in the 30 end processing of many
small nuclear and nucleolar RNAs (9,21,25,26,30,37,38).
Although we have extensively investigated whether similar
defects in 30 end processing of such sn(o)RNAs upon
knock-down of MPP6, C1D or hMtr4p occur in
human cells, we failed to detect any accumulating
precursors. In yeast, it has been shown that for several
exosome substrates, such as the U4 and U5 snRNA,
other 30–50 exoribonucleases can be involved in the 30 end
maturation of these RNAs as well (39). Currently, it is
unknown whether the failure to detect such processing
intermediates in human cells is due to processing factor
redundancy or to the low abundance of sn(o) RNA
precursors in these cells.
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